• 

  January 27, 2025

  Further Unlocking the Potential of 4D Bioprinting for Heart Tissue Engineering

  R.D. Solorzano

• 

  January 10, 2025

  Aspect Biosystems Secures $115M Series B to Advance Bioprinted Tissue Therapeutics

  R.D. Solorzano

• 

  January 7, 2025

  Stanford Open Source 3D Extrusion Bioprinter By Mark Skylar-Scott Lab

  R.D. Solorzano

• 

  December 13, 2024

  JOIN C-STARS: Exploring the Future of Space BioFabrication and Manufacturing

  R.D. Solorzano

• 

  December 3, 2024

  EpiBone Secures Funding Convertible Note to Drive Global Expansion of Clinical Trials

  R.D. Solorzano

• 

  December 2, 2024

  Engineering the Future of Vascularized Tissues: Programmable Bioinks Take Center Stage

  R.D. Solorzano

• 

  December 2, 2024

  Carl Roth Partners with BIO INX to Advance 3D Bioprinting Accessibility

  R.D. Solorzano

• 

  November 27, 2024

  French Based Lattice Medical Wins Coveted US MedTech Innovator Mid-Stage Grand Prize

  R.D. Solorzano

• 

  November 26, 2024

  CELLINK’s Strategic Shift: Right-Sizing for Long-Term Profitability

  R.D. Solorzano

• 

  November 25, 2024

  Cellbricks Therapeutics Expands to the U.S., Launches Subsidiary in Cambridge, MA

  R.D. Solorzano